Birgit Gruenberger

2.7k total citations
58 papers, 1.6k citations indexed

About

Birgit Gruenberger is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Birgit Gruenberger has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 30 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Birgit Gruenberger's work include Colorectal Cancer Treatments and Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Cancer Treatment and Pharmacology (17 papers). Birgit Gruenberger is often cited by papers focused on Colorectal Cancer Treatments and Studies (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers) and Cancer Treatment and Pharmacology (17 papers). Birgit Gruenberger collaborates with scholars based in Austria, Germany and Netherlands. Birgit Gruenberger's co-authors include Thomas Gruenberger, Dietmar Tamandl, Beata Herberger, Markus Klinger, Klaus Kaczirek, Fritz Wrba, Harald Puhalla, Stefan Hacker, Patrick Starlinger and Christine Brostjan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Birgit Gruenberger

56 papers receiving 1.5k citations

Peers

Countries citing papers authored by Birgit Gruenberger

Since Specialization

Citations

This map shows the geographic impact of Birgit Gruenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Gruenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Gruenberger more than expected).

Fields of papers citing papers by Birgit Gruenberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Gruenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Gruenberger. The network helps show where Birgit Gruenberger may publish in the future.

Co-authorship network of co-authors of Birgit Gruenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Gruenberger. A scholar is included among the top collaborators of Birgit Gruenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Gruenberger. Birgit Gruenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial 2024 ·Cancers ·(unknown), Jonas Santol, Birgit Gruenberger, A. Lenauer, Friedrich Laengle, Josef Thaler, (unknown), Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger	1
2	Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement 2023 ·Frontiers in Oncology ·Hossein Taghizadeh, Angela Djanani, Wolfgang Eisterer, Armin Gerger, Birgit Gruenberger, Thomas Gruenberger, Holger Rumpold, Lukas Weiß, Thomas Winder, Ewald Wöll, Gerald W. Prager	2
3	Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response 2016 ·OncoImmunology ·Dominic Schauer, Patrick Starlinger, (unknown), (unknown), Thomas Maier, Alexandra Feldman, (unknown), Elisabeth Buchberger, (unknown), Andreas Spittler, Judith Stift, (unknown), Birgit Gruenberger, Thomas Gruenberger, Christine Brostjan	13
4	Treatment sequence of synchronously (liver) metastasized colon cancer 2016 ·Digestive and Liver Disease ·Thomas Gruenberger, Geerard L. Beets, Jean‐Luc Van Laethem, Philippe Rougier, Andrés Cervantes, Jean‐Yves Douillard, Joan Figueras, Birgit Gruenberger, Daniel G. Haller, Roberto Labianca, Geert Maleux, Arnaud Roth, Michel Ducreux, Wolff Schmiegel, Thomas Seufferlein, Eric Van Cutsem	14
5	Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases 2015 ·European Journal of Surgical Oncology ·Stefan Stremitzer, Judith Stift, Jagdeep Singh, Patrick Starlinger, Birgit Gruenberger, Dietmar Tamandl, Thomas Gruenberger	21
6	Deficiency in Thrombopoietin Induction after Liver Surgery Is Associated with Postoperative Liver Dysfunction 2015 ·PLoS ONE ·Stefanie Haegele, (unknown), David Pereyra, (unknown), Alice Assinger, Edith Fleischmann, Birgit Gruenberger, Thomas Gruenberger, Christine Brostjan, Patrick Starlinger	11
7	Evidence for Serotonin as a Relevant Inducer of Liver Regeneration After Liver Resection in Humans 2013 ·Hepatology ·Patrick Starlinger, Alice Assinger, Stefanie Haegele, (unknown), (unknown), Dominic Schauer, Peter Birner, Edith Fleischmann, Birgit Gruenberger, Christine Brostjan, Thomas Gruenberger	72
8	Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation 2012 ·British Journal of Cancer ·Patrick Starlinger, (unknown), Dominic Schauer, T. Maier, (unknown), (unknown), Dietmar Tamandl, Birgit Gruenberger, Thomas Gruenberger, Christine Brostjan	20
9	Thrombospondin‐1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes 2010 ·Journal of Thrombosis and Haemostasis ·Patrick Starlinger, Herwig P. Moll, Alice Assinger, (unknown), Konrad Höetzenecker, Birgit Gruenberger, Thomas Gruenberger, Irene Kuehrer, Sebastian F. Schoppmann, Michael Gnant, Christine Brostjan	49
10	Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study 2010 ·The Lancet Oncology ·Birgit Gruenberger, Johannes Schueller, (unknown), Fritz Wrba, Dietmar Tamandl, Klaus Kaczirek, R. Roka, (unknown), Thomas Gruenberger	187
11	Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen 2010 ·Cancer Chemotherapy and Pharmacology ·Martin Czejka, (unknown), André Farkouh, Birgit Gruenberger, Werner Scheithauer	2
12	Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases 2009 ·European Journal of Surgical Oncology ·Markus Klinger, (unknown), Stefan Hacker, Beata Herberger, Dietmar Tamandl, Marion Dorfmeister, Claus Koelblinger, Birgit Gruenberger, Thomas Gruenberger	123
13	Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study 2009 ·British Journal of Ophthalmology ·Katharina E. Schmid‐Kubista, Ilse Krebs, Birgit Gruenberger, Florian Zeiler, (unknown), Svatopluk Binder	12
14	Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The Perioperative Angiogenic Balance Is Sensitive to Systemic Thrombospondin-1 Levels 2008 ·Clinical Cancer Research ·Christine Brostjan, (unknown), Birgit Gruenberger, (unknown), (unknown), (unknown), R. Roka, Thomas Gruenberger	25
15	Systemic Bevacizumab Therapy for Exudative Neovascular Age-Related Macular Degeneration (BEAT-AMD-Study) 2008 ·Investigative Ophthalmology & Visual Science ·Katharina E. Schmid‐Kubista, Ilse Krebs, Birgit Gruenberger, (unknown), Susanne Binder	2
16	Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases 2008 ·European Journal of Surgical Oncology ·(unknown), Markus Klinger, Stefan Hacker, Fritz Wrba, Birgit Gruenberger, Thomas Gruenberger	64
17	Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma 2008 ·Annals of Surgical Oncology ·Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, Harald Puhalla, Markus Klinger, Thomas Gruenberger	120
18	Assessment of the role of hepatitis C,Helicobacter pyloriand autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients 2008 ·Acta Oncologica ·Birgit Gruenberger, (unknown), Marlene Troch, W. Hauff, Julius Lukas, Berthold Streubel, Leonhard Muellauer, Andreas Chott, Markus Raderer	22
19	Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases 2008 ·BMC Cancer ·Birgit Gruenberger, Werner Scheithauer, (unknown), Christoph Zielinski, Dietmar Tamandl, Thomas Gruenberger	90
20	Selective resection of colorectal liver metastases 2006 ·European Journal of Surgical Oncology ·Dietmar Tamandl, Birgit Gruenberger, Beata Herberger, Sebastian F. Schoppmann, Martin Bodingbauer, Martin Schindl, Harald Puhalla, Edith Fleischmann, Wolfgang Schima, R. Jakesz, Friedrich Laengle, Thomas Gruenberger	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact